NewsStocksHindustan Agrigenetics Announces Major Board Restructuring and Appointment of New DirectorsHindustan Agrigenetics Announces Major Board Restructuring and Appointment of New Directors
Hindustan Agrigenetics Limited has announced significant changes to its board structure and leadership team. Dr. Vidya Jonnalagadda, with over 40 years of experience in biology research and teaching, has been appointed as a woman Independent Director. Five board members have resigned, while Mr. Pritam Kapur will continue as Managing Director until December 15, 2025, after which Mr. Rajendra Naniwadekar will take over. The company has also formed three new statutory committees: Audit, Nomination and Remuneration, and Stakeholders Relationship. These changes are in compliance with SEBI regulations and will be subject to shareholder approval in an upcoming General Meeting.
*this image is generated using AI for illustrative purposes only.
Hindustan Agrigenetics Limited, a company listed on the Bombay Stock Exchange (BSE: 519574), has undergone significant leadership changes following a successful open offer. The company has announced several key appointments and resignations, reshaping its board structure and leadership team.
Board Changes
The following changes have been made to the company's board:
- Mrs. Vidya Jonnalagadda appointed as a woman Independent Director
- Five board members resigned:
- Mrs. Chandani Kapur
- Mr. Sunny Srivastava
- Mr. Naren Parsai
- Mr. Pranav Kapur
- Ms. Mannu Kohli
- Mr. Pritam Kapur tendered his resignation but was requested to continue as Managing Director until December 15, 2025
- Mr. Rajendra Naniwadekar will take over as Managing Director from December 15, 2025
New Committee Formation
The company has formed three statutory committees:
- Audit Committee: Chaired by P.K. Rambabu
- Nomination and Remuneration Committee: Chaired by Ravi Shankar Kolathur
- Stakeholders Relationship Committee: Chaired by Shashank Vaidya
About Dr. Vidya Jonnalagadda
Dr. Vidya Sobhianaditya Jonnalagadda brings a wealth of experience to her new role:
| Aspect | Details |
|---|---|
| Experience | Over 40 years in biology research and teaching |
| Education | PhD from University of Pennsylvania, Philadelphia, PA |
| Research Background | Worked at prestigious institutions including Indian Institute of Science (Bangalore), Fox Chase Cancer Center (Philadelphia), Center for Cellular and Molecular Biology (Hyderabad), Osmania University (Hyderabad), and Massachusetts Institute of Technology (Cambridge, MA) |
| Teaching Experience | Transitioned to teaching about 20 years ago |
| Specialization | Genetics, molecular biology, virology, and immunology at undergraduate and post-graduate levels |
Appointment Details
The company has provided the following information regarding Dr. Jonnalagadda's appointment:
| Aspect | Details |
|---|---|
| Appointment Date | October 18, 2025 |
| Position | Non-Executive Independent Director |
| DIN | 06685501 |
| Relationship with Other Directors | None |
| Regulatory Status | Not a willful defaulter, not barred by SEBI or any other regulator |
Corporate Governance
Hindustan Agrigenetics Limited has emphasized that Dr. Jonnalagadda's appointment aligns with regulatory requirements. The company has confirmed that the appointee has no relationships with existing directors and meets all necessary regulatory criteria.
The Board meeting where these decisions were made commenced at 5:00 pm (IST) and concluded at 5:45 pm (IST) on October 18, 2025. The appointments and changes are in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
These strategic changes to the Board and leadership team, including Dr. Jonnalagadda's extensive background in biology and research, could potentially bring valuable insights to Hindustan Agrigenetics Limited, a company operating in the agrigenetics sector. Shareholders will have the opportunity to approve these appointments in an upcoming General Meeting.
